Legend Biotech
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $186,523 | $93,991 | $79,464 | $96,013 |
Gross Profit | 130,703 | 33,530 | 41,663 | 52,534 |
EBITDA | -36,601 | -112,142 | -115,702 | -61,820 |
EBIT | -41,970 | -117,864 | -121,053 | -66,991 |
Net Income | -18,196 | -59,793 | -144,818 | -62,207 |
Net Change In Cash | 186,523 | 93,991 | 79,464 | 96,013 |
Free Cash Flow | -20,967 | -6,605 | -118,651 | -66,321 |
Cash | 201,684 | 897,930 | 1,278,070 | 963,470 |
Basic Shares | 182,602 | 182,005 | 181,911 | 181,788 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $285,143 | $117,005 | $89,792 | $75,676 |
Gross Profit | 120,478 | 51,642 | -223,554 | -156,484 |
EBITDA | -421,765 | -437,436 | -379,108 | -303,413 |
EBIT | -442,216 | -455,828 | -393,025 | -313,346 |
Net Income | -518,254 | -446,349 | -386,209 | -303,477 |
Net Change In Cash | 285,143 | 117,005 | 89,792 | 75,676 |
Free Cash Flow | -505,972 | -222,304 | -245,577 | -272,781 |
Cash | 1,278,070 | 786,031 | 688,938 | 455,689 |
Basic Shares | 176,082 | 159,041 | 140,851 | 118,152 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.10 |
2024-03-31 | -$0.16 |
2023-12-31 | -$0.80 |
2023-09-30 | -$0.34 |
